These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18823696)

  • 1. Editorial comment on: Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.
    Chapple C
    Eur Urol; 2009 Jan; 55(1):120. PubMed ID: 18823696
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin A and lower urinary tract symptoms: non multa, sed multum (not many, but much).
    Lazzeri M
    Eur Urol; 2009 Jan; 55(1):59-61. PubMed ID: 18835657
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.
    Apostolidis A; Dasgupta P; Denys P; Elneil S; Fowler CJ; Giannantoni A; Karsenty G; Schulte-Baukloh H; Schurch B; Wyndaele JJ;
    Eur Urol; 2009 Jan; 55(1):100-19. PubMed ID: 18823697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A for the treatment of lower urinary tract disorders.
    Yokoyama T; Chancellor MB; Oguma K; Yamamoto Y; Suzuki T; Kumon H; Nagai A
    Int J Urol; 2012 Mar; 19(3):202-15. PubMed ID: 22220916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
    Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
    Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for urogenital conditions.
    Eccleston KJ; Woolley PD
    Int J STD AIDS; 2008 Dec; 19(12):797-9. PubMed ID: 19050206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic floor spasm as a cause of voiding dysfunction.
    Kuo TL; Ng LG; Chapple CR
    Curr Opin Urol; 2015 Jul; 25(4):311-6. PubMed ID: 26049874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin infiltrations versus local anaesthetic infiltrations in pelvic floor myofascial pain: Multicentre, randomized, double-blind study.
    Levesque A; Ploteau S; Michel F; Siproudhis L; Bautrant E; Eggermont J; Rabischong B; Volteau C; Perrouin-Verbe MA; Labat JJ
    Ann Phys Rehabil Med; 2021 Jan; 64(1):101354. PubMed ID: 31981833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment on the use of botulinum toxin.
    Moore AP
    Eur J Neurol; 2012 Mar; 19(3):357-8. PubMed ID: 22040329
    [No Abstract]   [Full Text] [Related]  

  • 11. Applications of botulinum toxin to the female pelvic floor: Botulinum toxin for genito-pelvic pain penetration disorder and chronic pelvic pain in women.
    Karp BI; Stratton P
    Toxicon; 2023 Jul; 230():107162. PubMed ID: 37201800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on '5 year experience with incobotulinumtoxinA (Xeomin(®) ) the first botulinum toxin drug free of complexing proteins'.
    Aoki KR
    Eur J Neurol; 2012 Mar; 19(3):355-6. PubMed ID: 21999802
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin A for the Treatment of Overactive Bladder.
    Hsieh PF; Chiu HC; Chen KC; Chang CH; Chou EC
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26938559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: A pilot study of botulinum toxin a for male chronic pelvic pain syndrome.
    Berger RE
    J Urol; 2011 Apr; 185(4):1303. PubMed ID: 22098965
    [No Abstract]   [Full Text] [Related]  

  • 16. [Botulinum toxin (BoNT) : Short form of a European consensus panel report regarding recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions].
    Schulte-Baukloh H
    Urologe A; 2010 Jan; 49(1):56-63. PubMed ID: 19876612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of botulinum toxin type a in the treatment of refractory postoperative dyspareunia.
    Park AJ; Paraiso MFR
    Obstet Gynecol; 2009 Aug; 114(2 Pt 2):484-487. PubMed ID: 19622971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary: Asian consensus recommendations on the aesthetic usage of botulinum toxin type A.
    Kane MA
    Dermatol Surg; 2013 Dec; 39(12):1861-7. PubMed ID: 24299575
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Athanassios Oeconomou, Helmut Madersbacher, Gustav Kiss, Thomas J. Berger, Michael Melekos and Peter Rehder. Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? a review of the literature. Eur Urol 2008;54:765-77.
    Brisinda G; Vanella S; Maria G
    Eur Urol; 2009 Jul; 56(1):e10-1; author reply e12-3. PubMed ID: 19375845
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin type A for the treatment of urinary tract dysfunction in neurological disorders.
    O'Leary M; Dierich M
    Urol Nurs; 2010; 30(4):228-34. PubMed ID: 20949807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.